Clinical Research Directory
Browse clinical research sites, groups, and studies.
TriCalm Hydrogel® in the Treatment of Immunotherapy-Related Pruritus
Sponsor: University of California, San Diego
Summary
This is a phase 2, randomized, open-label, single-center study that will assess the efficacy of TriCalm Hydrogel®, a topical gel containing strontium, for treating pruritus related to immune checkpoint inhibitors (ICIs).
Official title: A Phase 2 Randomized Study of TriCalm Hydrogel® in the Treatment of Immunotherapy-Related Pruritus
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
28
Start Date
2025-01-31
Completion Date
2028-12
Last Updated
2026-02-24
Healthy Volunteers
No
Conditions
Interventions
Tricalm Hydrogel
TriCalm Hydrogel® is a topical gel that allows rapid administration to areas of the skin. TriCalm Hydrogel® is available over-the-counter and contains the active ingredient, aluminum acetate 0.2%, and inactive ingredient, strontium chloride hexahydrate.
Triamcinolone acetonide 0.1% cream
Triamcinolone acetonide 0.1% cream is a topical steroid cream that will be applied directly to the skin.
Locations (1)
University of California San Diego
La Jolla, California, United States